Home › Depression › NCT06997549
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
RecruitingObservational study
Who can join
Ages 5 to 100 · All sexes
Full eligibility criteria
Inclusion Criteria: * Male or female reported in database and not an invalid entry * Age reported and not an invalid entry * Treatment date in 2011 or later. Exclusion Criteria: • Incomplete information on treatment parameters
About the study
The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness
What is being tested
- Patients treated with NeuroStar TMS (device)
- Patients treated with Esketamine (drug)
Sponsor: Neuronetics · Participants: 12,000 · Started: May 15, 2025
Contact the study team
- Neha Goyal · Phone: 7635281599
- Eleanor Cole, PhD · Phone: 415-724-7960
Official record on ClinicalTrials.gov — NCT06997549
Locations in the U.S.
| Pennsylvania | Neuronetics, Malvern |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.